thiazoles has been researched along with meropenem in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campos-Rivera, MP; Escalante-Fuentes, WG; Ocampo-Candiani, J; Pucci, MJ; Vera-Cabrera, L; Welsh, O | 1 |
| Bajaksouzian, S; Beanan, JM; Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Jacobs, M; Olson, R; Page, MG; Russo, TA | 1 |
| Hackel, M; Higgins, PG; Page, MG; Seifert, H; Stefanik, D | 1 |
| Dantier, C; Desarbre, E; Gebhardt, K; Hofer, B; Page, MG; Schmitt-Hoffmann, A | 1 |
| Adkin, R; Hope, R; Livermore, DM; Mushtaq, S; Woodford, N | 1 |
| Hornsey, M; Phee, L; Stubbings, W; Wareham, DW | 1 |
| Kassu, M; Kim, C; Kirby, JE; Manetsch, R; Smith, KP | 1 |
| Chen, W; Li, GB; Li, R; Mou, L; Qian, S; Su, H; Wang, Z; Yan, YH; Yang, H; Yang, L; Zhou, C | 1 |
8 other study(ies) available for thiazoles and meropenem
| Article | Year |
|---|---|
In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.
Topics: Anti-Bacterial Agents; Clavulanic Acid; Drug Therapy, Combination; Econazole; Humans; Imipenem; In Vitro Techniques; Meropenem; Mycetoma; Nocardia; Nocardia Infections; Quinolones; Thiazoles; Thienamycins | 2010 |
In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Interactions; Meropenem; Microbial Sensitivity Tests; Monobactams; Rats; Rodent Diseases; Siderophores; Thiazoles; Thienamycins; Treatment Outcome | 2011 |
In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Gene Expression; Humans; Meropenem; Microbial Sensitivity Tests; Monobactams; Thiazoles; Thienamycins | 2012 |
Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli.
Topics: Acinetobacter; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterobacteriaceae; Imipenem; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Monobactams; Pseudomonas aeruginosa; Thiazoles; Thienamycins | 2013 |
Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; DNA, Bacterial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Hospitals; Humans; Meropenem; Microbial Sensitivity Tests; Monobactams; Polymerase Chain Reaction; Sequence Analysis, DNA; Thiazoles; Thienamycins; United Kingdom | 2013 |
In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens.
Topics: Anti-Bacterial Agents; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Meropenem; Microbial Sensitivity Tests; Monobactams; Thiazoles; Thienamycins | 2013 |
Pyrazole-Thiazole Core-Containing Analogs Exhibit Adjunctive Activity with Meropenem against Carbapenem-Resistant Enterobacteriaceae (CRE).
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Dose-Response Relationship, Drug; Meropenem; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Structure-Activity Relationship; Thiazoles | 2021 |
Design, Synthesis, and Biological Evaluation of New 1H-Imidazole-2-Carboxylic Acid Derivatives as Metallo-β-Lactamase Inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carboxylic Acids; Imidazoles; Meropenem; Monobactams; Thiazoles | 2022 |